4.7 Review

Metabonomic Profiling of Bladder Cancer

期刊

JOURNAL OF PROTEOME RESEARCH
卷 14, 期 2, 页码 587-602

出版社

AMER CHEMICAL SOC
DOI: 10.1021/pr500966h

关键词

bladder cancer; metabonomics; biomarker; LC-MS; GC-MS; NMR

资金

  1. Singapore Ministry of Health's National Medical Research Council [R-176-000-119-213]
  2. National University of Singapore President Graduate Fellowship

向作者/读者索取更多资源

Early diagnosis and life-long surveillance are clinically important to improve the long-term survival of bladder cancer patients. Currently, a noninvasive biomarker that is as sensitive and specific as cystoscopy in detecting bladder tumors is lacking. Metabonomics is a complementary approach for identifying perturbed metabolic pathways in bladder cancer. Significant progress has been made using modern metabonomic techniques to characterize and distinguish bladder cancer patients from control subjects, identify marker metabolites, and shed insights on the disease biology and potential therapeutic targets. With its rapid development, metabonomics has the potential to impact the clinical management of bladder cancer patients in the future by revolutionizing the diagnosis and life-long surveillance strategies and stratifying patients for diagnostic, surgical, and therapeutic clinical trials. An introduction to metabonomics, typical metabonomic workflow, and critical evaluation of metabonomic investigations in identifying biomarkers for the diagnosis of bladder cancer are presented.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

Model-Based Risk Prediction of Rivaroxaban with Amiodarone for Moderate Renal Impaired Elderly Population

Ziteng Wang, Eleanor Jing Yi Cheong, Pipin Kojodjojo, Eric Chun Yong Chan

Summary: Concurrent use of rivaroxaban and amiodarone increases the risk of bleeding. The study found that human renal organic anion transporter 3 (hOAT3) plays a key role in the renal secretion of rivaroxaban and amiodarone inhibits hOAT3. When prescribed together, a dose reduction of rivaroxaban to 10 mg in elderly people with moderate renal impairment results in persistently higher rivaroxaban peak concentrations. To manage the increased bleeding risk, a further dose reduction of rivaroxaban to 2.5 mg twice daily is recommended.

CARDIOVASCULAR DRUGS AND THERAPY (2023)

Article Chemistry, Analytical

Transesterification of Indazole-3-carboxamide Synthetic Cannabinoids: Identification of Metabolite Biomarkers for Diagnosing Co-abuse of 5F-MDMB-PINACA and Alcohol

Ziteng Wang, Ching Yee Fong, Evelyn Mei Ling Goh, Hooi Yan Moy, Eric Chun Yong Chan

Summary: Concurrent use of synthetic cannabinoids (SCs) and alcohol has been observed among drug abusers. This study investigated the susceptibility of three indazole-3-carboxamide type SCs to transesterification in the presence of ethanol, as well as its potential augmented toxicity. Results showed that all three SCs underwent transesterification to ethyl ester analogs in the presence of ethanol, which was time- and concentration-dependent. The co-abuse of SCs and alcohol could lead to increased toxicity and further research is warranted.

JOURNAL OF ANALYTICAL TOXICOLOGY (2023)

Article Biochemical Research Methods

Urinary metabolomics identified metabolic disturbance associated with polycystic ovary syndrome

Zhandong Yang, Xuzi Cai, Xiaoxia Xu, Zengmei Xu, Simin Ye, Yan Wang, Yanjun Hong, Baochun Shen, Qiongfeng Liao, Zhiyong Xie, Xuefeng Wang

Summary: This study revealed metabolic disturbances associated with polycystic ovary syndrome (PCOS) using urinary metabolomics. By combining quantitative analysis and enrichment analysis, metabolic pathways related to PCOS, especially glycerophospholipid metabolism and tryptophan metabolism, were identified. Additionally, seven tryptophan-kynurenine metabolites were found to be up-regulated in PCOS and showed significant correlations with PCOS clinical features.

ANALYTICAL BIOCHEMISTRY (2022)

Article Cardiac & Cardiovascular Systems

Simvastatin, but Not Atorvastatin, Is Associated with Higher Peak Rivaroxaban Serum Levels and Bleeding: an Asian Cohort Study from Singapore

Xin Qin Soh, Doreen Su-Yin Tan, Eric Chun Yong Chan

Summary: This study identifies a potential association between concurrent use of simvastatin and rivaroxaban with bleeding events in Singaporean Asians.

CARDIOVASCULAR DRUGS AND THERAPY (2023)

Article Pharmacology & Pharmacy

Identification of Infigratinib as a Potent Reversible Inhibitor and Mechanism-Based Inactivator of CYP2J2: Nascent Evidence for a Potential In Vivo Metabolic Drug-Drug Interaction with Rivaroxaban

Lloyd Wei Tat Tang, Guoyi Wu, Eric Chun Yong Chan

Summary: This study found that Infigratinib has a potent competitive inhibition and mechanism-based inactivation effect on CYP2J2, and predicted that its coadministration with rivaroxaban may result in a drug-drug interaction, increasing the risk of major bleeding.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2022)

Article Plant Sciences

Integrated microbiome-metabolomics analysis reveals the potential therapeutic mechanism of Zuo-Jin-Wan in ulcerative colitis

Ying Cai, Siju Li, Xiaojun Zhang, Xueqin Cao, Deliang Liu, Yanglu Zhu, Simin Ye, Zengmei Xu, Qiongfeng Liao, Yanjun Hong, Zhiyong Xie

Summary: This study revealed that ZJW could alleviate DSS-induced UC in rats by modulating the interaction between gut microbiota and host cometabolites.

PHYTOMEDICINE (2022)

Article Agriculture, Multidisciplinary

Lactobacillus paracasei IMC 502 ameliorates type 2 diabetes by mediating gut microbiota-SCFA-hormone/inflammation pathway in mice

Yuxiang Gu, Haoran Chen, Xing Li, Dan Li, Yue Sun, Lin Yang, Ying Ma, Eric Chun Yong Chan

Summary: This study found that Lactobacillus paracasei IMC 502 can prevent and alleviate type 2 diabetes by mediating the gut microbiota-SCFA-hormone/inflammation pathway.

JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE (2023)

Article Pharmacology & Pharmacy

Development and verification of a physiologically based pharmacokinetic model of dronedarone and its active metabolite N-desbutyldronedarone: Application to prospective simulation of complex drug-drug interaction with rivaroxaban

Jacqueline Wen Hui Leow, Xiao Jun Ang, Eric Chun Yong Chan

Summary: A physiologically based pharmacokinetic (PBPK) model was developed to study the drug-drug interaction between dronedarone and rivaroxaban, and the simulation results showed that reducing the dose of rivaroxaban to at least 15 mg in subjects with mild renal impairment can achieve a better balance of risk and benefit.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Urology & Nephrology

5-alpha reductase inhibitors and MRI prostates: actively reducing prostate sizes and ambiguity

Ziting Wang, Kaiying Wang, Han Yang Ong, Woon Chau Tsang, Qing Hui Wu, Edmund Chiong

Summary: This study investigates the impact of 5-alpha reductase inhibitor (5-ARI) therapy on the MRI findings and biopsy yield in patients with suspected prostate cancer. The results show significant differences in imaging and biopsy characteristics between patients receiving and not receiving 5-ARI therapy, suggesting that 5-ARI use may confound MRI findings.

BMC UROLOGY (2023)

Review Urology & Nephrology

The impact of body mass index on oncological and surgical outcomes of patients undergoing nephrectomy: a systematic review and meta-analysis

Chloe S. H. Ong, Terence Y. X. Law, Alex Mok, Kenny S. C. Ho, Ziting Wang, Edmund Chiong, Ho Yee Tiong, Jeremy Y. C. Teoh

Summary: This study aimed to evaluate the impact of body mass index (BMI) on the outcomes of patients who underwent nephrectomy. The results showed that higher BMI was associated with improved long-term oncological survival, while lower BMI was associated with better surgical outcomes.

BJU INTERNATIONAL (2023)

Article Pharmacology & Pharmacy

Unraveling Complexities in the Absorption and Disposition Kinetics of Abiraterone via Iterative PBPK Model Development and Refinement

Eleanor Jing Yi Cheong, Sheng Yuan Chin, Zheng Wei Ng, Ting Jian Yap, Ervin Zhi Bin Cheong, Ziteng Wang, Eric Chun Yong Chan

Summary: This study aims to develop a physiologically based pharmacokinetic (PBPK) model for abiraterone to investigate the potential associations between its concentrations and pharmacodynamic consequences, and optimize the dosage to achieve better therapeutic outcomes.

CLINICAL PHARMACOKINETICS (2023)

Article Pharmacology & Pharmacy

Investigating the relevance of CYP2J2 inhibition for drugs known to cause intermediate to high risk torsades de pointes

Jacqueline Wen Hui Leow, Yuxiang Gu, Eric Chun Yong Chan

Summary: This study investigated the inhibitory effects of 16 drugs with intermediate to high risk of torsades de pointes (TdP) on the metabolism of arachidonic acid (AA) to epoxyeicosatrienoic acid (EET) by cardiac cytochrome P450 2J2 (CYP2J2). The results showed that 11 out of the 16 drugs exhibited inhibitory effects on CYP2J2 metabolism of AA. Among the high TdP risk category drugs, vandetanib and bepridil had the highest inhibitory effects. Further research is needed to determine the role of CYP2J2 metabolism in cardiac electrophysiology and the in vivo evidence of drug-AA interactions.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2023)

Article Food Science & Technology

Risk assessment of cultured meat

Yuxiang Gu, Xing Li, Eric Chun Yong Chan

Summary: The production of cultured meat involves complex technologies and novel ingredients, which may introduce hazards and risks. Currently, there is a lack of systematic and in-depth risk assessment for cultured meat. Therefore, targeted and effective risk and safety assessment strategies should be adopted, and a harmonized regulatory framework should be established globally.

TRENDS IN FOOD SCIENCE & TECHNOLOGY (2023)

Article Biochemistry & Molecular Biology

Ciprofol is primarily glucuronidated by UGT1A9 and predicted not to cause drug-drug interactions with typical substrates of CYP1A2, CYP2B6, and CYP2C19

Lei Hou, Yingying Zhao, Shiyu Zhao, Xuexia Zhang, Xia Yao, Jianjun Yang, Ziteng Wang, Shuaibing Liu

Summary: This study systematically characterized the UGTs enzymes involved in the formation of M4 and the inhibitory effects of ciprofol and its metabolite M4 on P450s enzymes. In vitro-in vivo extrapolation and PBPK simulations were performed to predict potential drug-drug interactions caused by ciprofol.

CHEMICO-BIOLOGICAL INTERACTIONS (2024)

暂无数据